Chapter 43

  1. 1. Abbott A. 2006. Lyme disease: uphill struggle. Nature 439:524-525.
  2. Alban PS, Johnson PW, Nelson DR. 2000. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146:119-127.
  3. Anderson JF, Barthold SW, Magnarelli LA. 1990. Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol 28:2693-2699.
  4. Anonymous. 1989. The ominous spread of Borrelia burgdorferi infection. J Am Vet Med Assoc 194:1387-1391.
  5. Anonymous. 1994. Lyme borreliosis. MMWR 43:564-565, 571-572.
  6. Anonymous. 2007. [Lyme borreliose]. Robert Koch Institut. Available at http://www.rki.de/cln_091/nn_466802/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber__Mbl__LymeBorreliose.html. Accessed 7/4/10.
  7. Appel MJG. 1990. Lyme disease in dogs and cats. Compend Contin Educ Pract Vet 12:617-626.
  8. Appel MJG, Allan S, Jacobson RH, et al. 1993. Experimental Lyme diseases in dogs produces arthritis and persistent infection. J Infect Dis 167:651-654.
  9. Arteaga F, Golightly MG, Garcia Perez A, et al. 1998. Disparity between serological reactivity to Borrelia burgdorferi and evidence of past disease in a high-risk group. Clin Infect Dis 27:1210-1213.
  10. Artsob H, Baarker IK, Fister R, et al. 1993. Serological studies on the infection of dogs in Ontario with Borrelia burgdorferi, the etiological agent of Lyme disease. Can Vet J 34:543-548.
  11. Assous MV, Wilamowski A. 2009. Relapsing fever borreliosis in Eurasia—forgotten, but certainly not gone! Clin Microbiol Infect 15:407-414.
  12. Azuma Y, Isogai E, Isogai H, et al. 1994. Canine Lyme disease: clinical and serological evaluations in 21 dogs in Japan. Vet Rec 134:369-372.
  13. Azuma Y, Kawamura K, Isogai H, et al. 1993. Neurologic abnormalities in two dogs with suspected Lyme disease. Microbiol Immunol 37:325-329.
  14. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187:1187-1199.
  15. Bacon RM, Kugeler KJ, Mead PS, et al. 2008. Surveillance for Lyme disease—United States, 1992–2006. MMWR 57:1-9. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5710a1.htm. Accessed 1/10/09.
  16. Banerjee S, Stephen C, Fernando K, et al. 1996. Evaluation of dogs as sero-indicators of the geographic distribution of Lyme borreliosis in British Columbia. Can Vet J 37:168-169.
  17. Baranton G, Postic D, Saint GI, et al. 1992. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378-383.
  18. Barber RM, Li Q, Diniz PPVP, et al. 2010. Evaluation of brain tissue or cerebrospinal fluid with broadly reactive polymerase chain reaction for Ehrlichia, Anaplasma, spotted fever group Rickettsia, Bartonella, and Borrelia species in canine neurological diseases (109 cases). J Vet Intern Med 24:372-378.
  19. Barbour AG, Fish D. 1993. The biological and social phenomenon of Lyme disease. Science 260:1610-1616.
  20. Barthold SW. 1999. Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species. Infect Immun 67:36-42.
  21. Barthold SW, Feng S, Bockenstedt LK. 1997. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 25(Suppl 1):S9-S17.
  22. Barthold SW, Fikrig E, Bockenstedt LK, et al. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun 63:2255-2261.
  23. Barthold SW, Levy SA, Fikrig E, et al. 1995. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J Am Vet Med Assoc 207:1435-1440.
  24. Bauerfeind R, Kreis U, Weiss R, et al. 1998. Detection of Borrelia burgdorferi in urine specimens from dogs by a nested polymerase chain reaction. Zentbl Bakteriol 287:347-361.
  25. Beall MJ, Chandrashekar R, Eberts MD, et al. 2008. Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector-Borne Zoon Dis 8:455-464.
  26. Bernadino AL, Kaushal D, Philipp MT. 2009. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis 199:1378-1388.
  27. Bhide M, Yilmaz Z, Golcu E, et al. 2008. Seroprevalence of anti–Borrelia burgdorferi antibodies in dogs and horses in turkey. Ann Agric Environ Med 15:85-90.
  28. Bockenstedt LK, Mao J, Hodzic E, et al. 2002. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J Infect Dis 186:1430-1437.
  29. Bohme M, Schwenecke S, Fuchs E, et al. 1992. Screening of blood donors and recipients for Borrelia burgdorferi antibodies: no evidence of B. burgdorferi infection transmitted by transfusion. Infusionsther Transfusionsmed 19:204-207.
  30. Bosler EM, Cohen DP, Schulze TL, et al. 1988. Host responses to Borrelia burgdorferi in dogs and horses. NY Acad Sci 539:221-234.
  31. Bowman D, Little SE, Lorentzen L, et al. 2009. Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based serologic survey. Vet Parasitol 160:138-148.
  32. Bradley JF, Johnson RC, Goodman JL. 1994. The persistence of spirochetal nucleic acids in active Lyme arthritis. Am Intern Med 120:487-489.
  33. Breitschwerdt EB, Geoly FJ, Meuten DJ, et al. 1996. Myocarditis in mice and guinea pigs experimentally infected with a canine-origin Borrelia isolate from Florida. Am J Vet Res 57:505-511.
  34. Breitschwerdt EB, Nicholson WL, Kiehl AB, et al. 1994. Natural infections with Borrelia spirochetes in two dogs from Florida. J Clin Microbiol 32:352-357.
  35. Brorson Ø, Brorson SH. 1997. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25:240-246.
  36. Brown RN, Lane RS. 1992. Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science 256:1439-1442.
  37. Brown RN, Peot MA, Lane RS. 2006. Sylvatic maintenance of Borrelia burgdorferi (Spirochetales) in Northern California: untangling the web of transmission. J Med Entomol 43:743-761.
  38. Brown SL, Hansen SL, Langone JJ. 1999. Role of serology in the diagnosis of Lyme disease. JAMA 282:62-66.
  39. Brune K, Rollinghoff M, Gessner A. 1999. Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol 37:1958-1963.
  40. Brunner M, Sigal LH. 2000. Immune complexes from serum of patients with Lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing. J Infect Dis 182:534-539.
  41. Bunikis J, Tsao J, Garpmo U. 2004. Typing of Borrelia relapsing fever group strains. Emerg Infect Dis 10:1661-1664.
  42. Bunikis J, Tsao J, Luke CJ, et al. 2004. Borrelia burgdorferi infection in a natural population of Peromyscus leucopus mice: a longitudinal study in an area where Lyme borreliosis is highly endemic. J Infect Dis 189:1515-1523.
  43. Burgess EC. 1986. Experimental inoculation of dogs with Borrelia burgdorferi. Zentralbl Bakteriol Hyg (A) 263:427-434.
  44. Burgess EC. 1992. Experimentally induced infection of cats with Borrelia burgdorferi. Am J Vet Res 53:1507-1511.
  45. Burgess EC, Schneider E, Bosler E. 1989. Testing for Borrelia burgdorferi. J Am Vet Med Assoc 195:844-846.
  46. Burkot TR, Mullen GR, Anderson R, et al. 2001. Borrelia lonestari DNA in adult Amblyomma americanum ticks, Alabama. Emerg Infect Dis 7:471-474.
  47. Burkot TR, Piesman J, Wirtz RA. 1994. Quantitation of the Borrelia burgdorferi outer surface protein A in Ixodes scapularis: fluctuations during the tick life cycle, doubling times, and loss while feeding. J Infect Dis 170:883-889.
  48. Burkot TR, Schriefer ME, Larsen SA. 1997. Cross-reactivity to Borrelia burgdorferi proteins in serum samples from residents of a tropical country nonendemic for Lyme disease. J Infect Dis 175:466-469.
  49. Callister SM, Jobe DA, Schell RF, et al. 2000. Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected Ixodes scapularis ticks. J Clin Microbiol 38:3670-3674.
  50. Canica MM, Nato F, du Merle L, et al. 1993. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis. 25:441-448.
  51. Carlson D, Hernandez J, Bloom B, et al. 1999. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 42:2705-2709.
  52. Castellaw AH, Showers J, Goddard J, et al. 2010. Detection of vector-borne agents in Lone star ticks, Amblyomma americanum (Acari:Ixodidae), from Mississippi. J Med Entomol 47:473-476.
  53. Center for Disease Control and Prevention. 2009. Stop Ticks. http://cdc.gov/features/stopticks. Accessed 7/4/10.
  54. Cerri D, Farina R, Andreani R, et al. 1994. Experimental infection of dogs with Borrelia burgdorferi. Res Vet Sci 57:256-258.
  55. Champion CI, Blanco DR, Skare JT, et al. 1994. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun 62:2653-2661.
  56. 55a. Chandrashekar R, Mainville CA, Beall MJU, et al. 2010. Performance of a commercially available in-clinic ELISA for the detection of antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis antigen in dogs. Am J Vet Res 71:1443-1450.
  57. Chang YF, Novosel V, Chang CF, et al. 2001. Experimental induction of chronic borreliosis in adult dogs exposed to Borrelia burgdorferi-infected ticks and treated with dexamethasone. Am J Vet Res 62:1104-1112.
  58. Chou J, Wünschmann A, Hodzic E. 2006. Detection of Borrelia burgdorferi DNA in tissues from dogs with presumptive Lyme borreliosis. J Am Vet Med Assoc 229:1260-1265.
  59. Chu HJ, Chaavez LG, Blumer BM, et al. 1992. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. J Am Vet Med Assoc 201:403-411.
  60. Cohen ND, Carter CN, Thomas MA, et al. 1990. Clinical and epizootiologic characteristics of dogs seropositive for Borrelia burgdorferi in Texas: 100 cases (1988). J Am Vet Med Assoc 197:893-898.
  61. Collares-Pereira M, S. Couceiro S, Franca I, et al. 2004. First isolation of Borrelia lusitaniae from a human patient. J Clin Microbiol 42:1316-1318.
  62. Coughlin RT, Fish D, Mather TN, et al. 1995. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB and the saponin adjuvant QS21. J Infect Dis 171:1049-1052.
  63. 61a. Couto CG, Lorentzen L, Beall MJ, et al. 2010. Serological study of selected vector-borne diseases in shelter dogs in central Spain using point-of-care assays. Vector Borne Zoonotic Dis 10:885-888.
  64. Dambach DM, Smith CA, Lewis RM, et al. 1997. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987–1992). Vet Pathol 34:85-170.
  65. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. 1997. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337:289-363.
  66. De Maria A, Primavera A. 2000. Possibility of the use of oral long-acting tetracyclines in the treatment of Lyme neuroborreliosis. Clin Infect Dis 31:848-849.
  67. Derdakova M, Lencakova D. 2005. Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology and epidemiology of Lyme borreliosis in Europe. Ann Agric Environ Med 12:165-172.
  68. De Silva AM, Fikrig E, Hodzik E, et al. 1998. Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis 177:395-400.
  69. De Silva AM, Fish D, Burkot TR, et al. 1997. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks. Infect Immun 65:3146-3150.
  70. DeSilva AM, Telford SR, Brunet LR, et al. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183:271-275.
  71. Des Vignes F, Piesman J, Heffernan R, et al. 2001. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 183:773-778.
  72. Diza E, Papa A, Vezyri E, et al. 2004. Borrelia valaisiana in cerebrospinal fluid. Emerg Infect Dis 10:1692-1693.
  73. Dolan MC, Maupin GO, Schneider BS, et al 2004. Control of immature Ixodes scapularis (Acari: Ixodidae) on rodent reservoirs of Borrelia burgdorferi in a residential community of southeastern Connecticut. J Med Entomol 41:1043-1054.
  74. Donta ST. 1997. Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 25:S52-S56.
  75. Dorward DW, Schwan TG, Garon CF. 1991. Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs and humans. J Clin Microbiol 29:1162-1170.
  76. Dotevall L, Hagberg L. 1999. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28:569-574.
  77. Dotevall L, Hageberg L. 2000. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis 30:410-411.
  78. Dressler F, Ackermann R, Steere AC. 1994. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis 169:313-318.
  79. Duncan AW, Correa MT, Levine JF, et al. 2005. The dog as a sentinel for human infection. Prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis 5:101-109.
  80. Dworkin MS, Anderson DE, Schwan TG, et al. 1998. Tick-borne relapsing fever in the Northwestern United States and Southwestern Canada. Clin Infect Dis 26:122-131.
  81. Dworkin MS, Schwan TG, Anderson DE. 2002. Tick-borne relapsing fever in North America. Med Clin North Am 86:417-432.
  82. Dworkin MS, Schwan TG, Anderson DE, et al. 2008. Tick-borne relapsing fever. Infect Dis Clin North Am 22:449-468.
  83. Elfassy OJ, Goodman FW, Levy SA, et al. 2001. Efficacy of an amitraz-impregnated collar in preventing transmission of Borrelia burgdorferi by adult Ixodes scapularis to dogs. J Am Vet Med Assoc 219:185-189.
  84. Endris RG, Cooke D, Amodie D, et al. 2002. Repellency and efficacy of 65% permethrin and selamectin spot-on formulations against Ixodes ricinus ticks on dogs. Vet Ther 3:64-71.
  85. Eng TR, Wilson ML, Speilman A, et al. 1988. Greater risk of Borrelia burgdorferi infection in dogs than in people. J Infect Dis 158:1410-1411.
  86. Eschner AK. 2008. Effect of passive immunoglobulin transfer on results of diagnostic tests for antibodies against Borrelia burgdorferi in pups born to a seropositive dam. Vet Ther 9:184-191.
  87. Falco RC, Smith HA, Fish D, et al. 1993. The distribution of canine exposure to Borrelia burgdorferi in a Lyme disease endemic area. Am J Public Health 83:1305-1310.
  88. Feder BM, Joseph RJ, Moroff SD, et al. 1991. Borrelia burgdorferi antibodies in canine cerebrospinal fluid, p 137. In Proceeding of the Annual ACVIM Forum, New York.
  89. Fekade D, Knox K, Hussein K, et al. 1996. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor α. N Engl J Med 335:311-315.
  90. Filipuzzi-Jenny E, Blot M, Schmid-Berger N, et al. 1993. Genetic diversity among Borrelia burgdorferi isolates: more than three genospecies? Res Microbiol 144:295-304.
  91. Foley J, Drazenovich N, Leutenegger CM, et al. 2007. Association between polyarthritis and thrombocytopenia and increased prevalence of vectorborne pathogens in Californian dogs. Vet Rec 160:159-162.
  92. Foley JE, Queen EV, Sacks B, et al. 2005. GIS-facilitated spatial epidemiology of tick-borne diseases in coyotes (Canis latrans) in northern and coastal California. Comp Immunol Microbiol Infect Dis 28:197-212.
  93. Font A, Closa JM, Mascort J. 1992. Lyme disease in dogs in Spain. Vet Rec 130:227-228.
  94. Frank JC. 1989. Taking a hard look at Borrelia burgdorferi. J Am Vet Med Assoc 194:1521.
  95. Fritz CL, Kjemtrup AM. 2003. Lyme borreliosis. J Am Vet Med Assoc 223:1234-1233.
  96. Fukunaga M, Koreki Y. 1995. The flagellin gene of Borrelia miyamotoi sp nov and its phylogenetic relationship among Borrelia species. FEMS Microbiol Lett 134:255-258.
  97. Gauthier DT, Mansfield LS. 1999. Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs. J Vet Diagn Invest 11:259-265.
  98. Georglis K, Peacocke M, Klempner MS. 1992. Fibroblasts protect the Lyme disease spirochete Borrelia burgdorferi from ceftriaxone in vitro. J Infect Dis 166:440-444.
  99. Gerber B, Eichenberger S, Haug K, et al. 2009. Association of urine protein excretion and infection with Borrelia burgdorferi sensu lato in Bernese Mountain dogs. Vet J 182:487-488.
  100. Gerber B, Eichenberger S, Haug K, et al. 2009. The dilemma with Lyme borreliosis in the dog with particular consideration of "Lyme nephritis." Schweiz Arch Tierheilkd 151:479-483.
  101. 98a. Gerber B, Eichenberger S, Joller-Jemelka HI, et al. 2010. Complement C3 in Bernese mountain dogs. Vet Clin Pathol 39:164-168.
  102. Gerber B, Eichenberger S, Wittenbrink MM, et al. 2007. Increased prevalence of Borrelia burgdorferi infections in Bernese mountain dogs: a possible breed predisposition. BMC Vet Res 3:15 (http://www.biomedcentral.com/1746-6148/3/15).
  103. Gerber B, Haug K, Eichenberger S, et al. 2009. Comparison of a rapid immunoassay for antibodies to the C6 antigen with conventional tests for antibodies to Borrelia burgdorferi in dogs. Vet Rec 165:594-597.
  104. Gerber MA, Shapiro ED, Bell GL, et al. 1995. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease. J Infect Dis 171:724-727.
  105. Gerber MA, Shapiro ED, Krause PJ, et al. 1994. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 170:231-234.
  106. Gern L. 2009. Life cycle of Borrelia burgdorferi sensu lato and transmission to humans. Curr Prob Dermatol 37:18-30, 2009.
  107. Gibson MD, Omran MT, Young CR. 1995. Experimental feline Lyme borreliosis as a model for testing Borrelia burgdorferi vaccines. Adv Exp Med Biol 383:73-82.
  108. Gibson MD, Young CR, Tawfik OM, et al. 1993. Borrelia burgdorferi infection of cats. J Am Vet Med Assoc 202:1786.
  109. Giudice E, Domina F, Britti D, et al. 2003. Clinical findings associated with Borrelia burgdorferi infection in the dog. Vet Res Commun 27(Suppl 1):767-770.
  110. Golde WT, Robinson-Dunn B, Stobierski MG, et al. 1998. Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto. J Clin Microbiol 36:1015-1019.
  111. Goldstein RE. 2010. Advances in the prevention and management of Borrelia burgdorferi infections in dogs. Proceedings ACVIM Forum, Anaheim, CA, June 9-12.
  112. Goldstein RE, Atwater DZ. 2006. Evaluation of serology and circulating immune complexes in dogs naturally infected with Borrelia burgdorferi [abstract]. J Vet Intern Med 20:713.
  113. Goldstein RE, Cordner AP, Sandler JL, et al. 2007. Microalbuminuria and comparison of serologic testing for exposure to Borrelia burgdorferi in nonclinical Labrador and golden retrievers. J Vet Diagn Invest 19:294-297.
  114. Gomes-Solecki MJC, Brisson DR, Dattwyler RJ. 2006. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine 24:4440-4449.
  115. Goossens HA, Maes JH, van den Bogaard AE. 2003. The prevalence of antibodies against B. burgdorferi, an indicator for Lyme borreliosis in dogs? A comparison of serological tests. Tijdschr Diergeneeskd 128:650-657.
  116. Gordillo-Perez G, Torres J, Soloorzano-Santos F, et al. 2007. Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico. Emerg Infect Dis 13:1556-1558.
  117. 113a. Gordillo-Perez G, Vargas M, Solorzano-Santos F, et al. 2009. Demonstration of Borrelia burgdorferi sensu stricto infection in ticks from the northeast of Mexico. Clin Microbiol Infect 15:496-498.
  118. Gorelova NB, Korenberg EI, Kovalevski IUV, et al 1996. [The isolation of Borrelia from the tick Ixodes trianguliceps (Ixodidae) and the possible significance of this species in the epizootiology of ixodid tick-borne borrelioses]. Parazitologiia 30:13-18.
  119. Grab DJ, Nyarko E, Barat NC, et al. 2007. Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine and matrix metalloprotease expression by human brain microvascular endothelial cells. Clin Vaccine Immunol 14:1420-1424.
  120. Granter SR, Barnhill RL, Hewins ME, et al. 1994. Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis. JAMA 272:1283-1285.
  121. Grauer GF, Burgess EC, Cooley AJ, et al. 1988. Renal lesions associated with Borrelia burgdorferi infection in a dog. J Am Vet Med Assoc 193:237-239.
  122. Greene CE. 1995. Unpublished data. University of Georgia, Athens, GA.
  123. Greene CE, Appel MJG, Straubinger RK. 1998. Lyme borreliosis, pp 282-293. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  124. Greene RT. 1989. Lameness and symptomatic Borrelia burgdorferi seropositivity in dogs. J Infect Dis 160:346-347.
  125. Greene RT. 1990. An update on the serodiagnosis of canine Lyme borreliosis. J Vet Intern Med 4:167-171.
  126. Greene RT. 1990. Lyme borreliosis, pp 508-515. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  127. Greene RT, Hirsch D, Rottman PL, et al. 1991. Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera. J Clin Microbiol 29:16-20.
  128. Greene RT, Levine JF, Breitchwerdt EB, et al. 1988. Antibodies to Borrelia burgdorferi in dogs in North Carolina. Am J Vet Res 49:473-476.
  129. Greene RT, Levine JF, Breitschwerdt EB, et al. 1988. Clinical and serologic evaluations of induced Borrelia burgdorferi infection in dogs. Am J Vet Res 49:752-757.
  130. Greene RT, Walker RL, Burgess EC, et al. 1988. Heterogeneity in immunoblot patterns obtained by using four strains of Borrelia burgdorferi and sera from naturally exposed dogs. J Clin Microbiol 26:2287-2291.
  131. Greene RT, Walker RL, Greene CE. 1991. Pseudospirochetes in animal blood being cultured for Borrelia burgdorferi. J Vet Diagn Invest 3:350-352.
  132. Greene RT, Walker RL, Nicholson WL, et al. 1988d. Immunoblot analysis of the immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs. J Clin Microbiol 26:648-653.
  133. Greene RT, Walker RL, Nicholson WL, et al. 1991. Comparison of an enzyme-linked immunosorbent assay to an indirect immunofluorescence assay for the detection of antibodies to Borrelia burgdorferi in the dog. Vet Microbiol 26:179-190.
  134. Gruntar I, Malovrh T, Murgia R, et al. 2001. Conversion of Borrelia garinii cystic forms to motile spirochetes in vivo. APMIS 109:383-388.
  135. Guerra MA, Walker E, Jones C, et al. 2002. Predicting the risk of Lyme disease: habitat suitability for Ixodes scapularis in the North Central United States. Emerg Infect Dis 8:289-297.
  136. Guerra MA, Walker ED, Kitron U. 2000. Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure. J Clin Microbiol 38:2628-2632.
  137. Guerra MA, Walker ED, Kitron U. 2001. Canine surveillance system for Lyme borreliosis in Wisconsin and Northern Illinois: geographic distribution and risk factor analysis. Am J Trop Med Hyg 65:546-552.
  138. 133a. Gunzman-Cornejo C, Robbins RG, Perez TM. 2007. The Ixodes (Acari: Ixodidae) of Mexico: parasite-host and host-parasite checklists. Zootaxa 1553:47-58.
  139. Gustafson JM, Burgess EC, Wachal MD, et al. 1993. Intrauterine transmission of Borrelia burgdorferi in dogs. Am J Vet Res 54:882-890.
  140. Halperin JJ, Shapiro ED, Logigian E, et al. 2007. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Neurology 69:91-102.
  141. Halperin T, Orr N, Cohen R, et al. 2006. Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpO). Acta Trop 98:189-195.
  142. Hansen K, Lebech AM. 1991. Lyme neuroborreliosis a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi specific immunoglobulin G, A, and M. Am Neurol 30:197-205.
  143. Harter L, Straubinger RK, Summers BA, et al. 1999. Up-regulation of inducible nitric oxide synthase mRNA in dogs experimentally infected with Borrelia burgdorferi. Vet Immunol Immunopathol 67:271-284.
  144. Hasin T, Davidovitch N, Cohen R, et al. 2006. Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med 255:148-155.
  145. Hauser U, Lehnert G, Wilske B. 1998. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol 5:456-462.
  146. Hayes EB, Piesman J. 2003. How can we prevent Lyme disease? N Eng J Med 348:2424-2430.
  147. Henriksson A, Link H, Cruz M, et al. 1986. Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). Ann Neurol 20:337-345.
  148. 142a. Herbert D, Eschner A. 2010. Seroprevalence of Borrelia burgdorferi-specific C6 antibody in dogs before and after implementation of a nonadjuvanted recombinant outer surface protein A vaccine in a Rhode Island small animal clinic. Vet Ther 11:E1-E9.
  149. 142b. Herrmann C, Gern L. 2010. Survival of Ixodes ricinus (Acari: Ixodidae) under challenging conditions of temeperature and humidity is influenced by Borrelia burgdorferi sensu lato infection. J Med Entomol 47:1196-1204.
  150. Hilton E, Tramontano A, DeVoti J, et al. 1997. Temporal study of immunoglobulin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 35:774-776.
  151. Hodzic E, Feng S, Barthold SW. 2000. Stability of Borrelia burgdorferi outer surface protein C under immune selection pressure. J Infect Dis 181:750-753.
  152. Holden K, Boothby JT, Kasten RW, et al. 2006. Co-detection of Bartonella henselae, Borrelia burgdorferi, and Anaplasma phagocytophilum in Ixodes pacificus ticks from California, USA. Vector Borne Zoonotic Dis 6:99-102.
  153. Hovius JW, Hovius KE, Oei A, et al. 2000. Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs. J Clin Microbiol 38:2611-2621.
  154. Hovius JW, Schuijt TJ, de Groot KA, et al. 2008. Preferential protection of Borrelia burgdorferi sensu strict by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis 198:1189-1197.
  155. Hovius KE, Beijer B, Rijpkema SG, et al. 1998. Identification of four Borrelia burgdorferi sensu lato species in Ixodes ricinus ticks collected from Dutch dogs. Vet Q 20:143-145.
  156. Hovius KE, Rijpkema STG, Westers P, et al. 1999. A serological study of cohorts of young dogs naturally exposed to Ixodes ricinus ticks indicates seasonal infection by Borrelia burgdorferi sensu lato. Vet Q 21:16-20.
  157. Hovius KE, Stark LAM, Bleumink-Pluym NMC, et al. 1999. Presence and distribution of Borrelia burgdorferi sensu lato species in internal organs and skin of naturally infected symptomatic and asymptomatic dogs as detected by polymerase chain reaction. Vet Q 21:54-58.
  158. Hubbard MJ, Baker AS, Cann KJ. 1998. Distribution of Borrelia burgdorferi s. l spirochaete DNA in British ticks (Argasidae and Ixodidae) since the 19th century, assessed by PCR. Med Vet Entomol 12:89-97.
  159. Humair PF. 2002. Birds and Borrelia. Int J Med Microbiol 291(Suppl)33:70-74.
  160. Hutton TA, Goldstein RE, Njaa BL, et al. 2008. Search for Borrelia burgdorferi in kidneys of dogs with suspected Lyme nephritis. J Vet Intern Med 22:860-865.
  161. Ivacic L, Reed KD, Mitchell PD, et al. 2007. A LightCycler TaqMan assay for detection of Borrelia burgdorferi sensu lato in clinical samples. Diagn Microbiol Infect Dis 57:137-143.
  162. Jacobsen M, Zhou D, Cepok S, et al. 2003. Clonal accumulation of activated CD8+ T cells in the central nervous system during the early phase of neuroborreliosis. J Infect Dis 187:963-973.
  163. Jacobson RH, Chang Y-F, Shin SJ. 1996. Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs. Semin Vet Med Surg 11:172-182.
  164. Jäderlund KH, Bergström K, Engenvall A, et al. 2009. Cerebrospinal fluid PCR and antibody concentrations against Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in dogs with neurological signs. J Vet Intern Med 23:669-672.
  165. Jäderlund KH, Egenvall A, Bergström K, et al. 2007. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in dogs with neurological signs. Vet Rec 160:825-831.
  166. Jaenson TG, Talleklint L. 1992. Incompetence of roe deer as reservoirs of the Lyme borreliosis spirochete. J Med Entomol 29:813-817.
  167. James AM, Liveris D, Wormser GP, et al. 2001. Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis 183:1810-1814.
  168. Jobe DA, Lovrich SD, Nelson JA, et al. 2006. Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area. Emerg Infect Dis 12:1039-1041.
  169. Johnson JL, Ginsberg HS, Zhioua E, et al. 2004. Passive tick surveillance, dog seropositivity, and incidence of human Lyme disease. Vector Borne Zoonotic Dis 4:137-142.
  170. Johnson RC, Kodner CB, Jurkovich PJ, et al. 1990. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents. Antimicrob Agents Chemother 34:2133-2136.
  171. Johnson SE, Swaminathan B, Moore P, et al. 1990. Borrelia burgdorferi survival in experimentally infected human blood processed for transfusion. J Infect Dis 162:557-559.
  172. Kalish RA, McHugh G, Granquist J, et al. 2001. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme Disease. Clin Infect Dis 33:780-785.
  173. Karch H, Huppertz HI, Bohme M, et al. 1994. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 32:2312-2314.
  174. Kaufman AC, Greene CE, McGraw RA. 1993. Optimization of polymerase chain reaction for the detection of Borrelia burgdorferi in biologic specimens. J Vet Diagn Invest 5:548-554.
  175. Kazmierczak JJ, Sorhage FE. 1993. Current understanding of Borrelia burgdorferi infection with emphasis on its prevention in dogs. J Am Vet Med Assoc 203:1524-1528.
  176. 168a. Keefe LM, Moro MH, Vinasco J, et al. 2009. The use of harvested white-tailed deer (Odocoileus virginanus) and geographic information system (GIS) methods to characterize distribution and locate spatial clusters of Borrelia burgdorferi and its vector Ixodes scapularis in Indiana. Vector-Borne Zoonotic Dis 9:671-680.
  177. 168b. Keirans JE, Hutcheson HJ, Durden LA, et al. 1996. Ixodes (Ixodes) scapularis (Acari: Ixodidae): redescription of all active stages, distribution, hosts, geographical variation, and medical and veterinary importance. J Med Enotmol 33:297-318.
  178. Keller D, Koster FT, Marks DH, et al. 1994. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. J Am Med Assoc 271:1764-1768.
  179. Kim D, Kordick D, Divers T, et al. 2006. In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin. J Vet Sci 7:355-359.
  180. Klempner MS, Hu LT, Evans J, et al. 2001. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Eng J Med 345:85-92.
  181. Korshus JB, Munderloh UG, Bey RF, et al. 2004. Experimental infection of dogs with Borrelia burgdorferi sensu stricto using Ixodes scapularis ticks artificially infected by capillary feeding. Med Microbiol Immunol (Berl) 193:27-34.
  182. Krupka I, Pantchev N, Lorentzen L, et al. 2007. Durch Zecken übertragbare bakterielle Infektionen bei Hunden: Seroprävalenzen von Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato und Ehrlichia canis in Deutschland. Prakt Tierarzt 88:776-788.
  183. 173a. Krupka I, Straubinger RK. 2010. Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto. Vet Clin Small Anim 40:1103-1119.
  184. Kuenzle S, von Büdingen H-C, Meier M, et al. 2007. Pathogen specific and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis. Infect Immun 75:3842-3847.
  185. Kuiper H, van Dam AP, Spanjaard L, et al. 1994. Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J Clin Microbiol 32:715-720.
  186. Kumi-Diaka J, Harris O. 1995. Viability of Borrelia burgdorferi in stored semen. Br Vet J 151:221-224.
  187. Kurtenbach KS, De Michelis HS, Sewell S, et al. 2002. The key roles of selection and migration in the ecology of Lyme borreliosis. Int J Med Microbiol 291(Suppl)33:152-154.
  188. 177a. Kybicová K, Schánilec P, Hulínská D, et al. 2009. Detection of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in dogs in the Czech republic. Vector Borne Zoonotic Dis 9:655-661.
  189. Labarthe N, de Campos Pereira M, Barbarini O, et al. 2003. Serologic prevalence of Dirofilaria immitis, Ehrlichia canis, and Borrelia burgdorferi infections in Brazil. Vet Ther 4:67-75.
  190. LaFleur RL, Callister SM, Dant JC, et al. 2010. One year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol 17:870-874.
  191. LaFleur RL, Dant JC, Wasomen TL, et al. 2009. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol 16:253-259.
  192. Lane RS, Quistad GB. 1998. Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis). J Parasitol 84:29-34.
  193. Lathrop SL, Ball R, Haver P, et al. 2002. Adverse event reports following vaccination for Lyme disease December 1998–July 2000. Vaccine 20:1603-1608.
  194. Layfield D, Guilfoile P. 2002. The prevalence of Borrelia burgdorferi (Spirochaetales: spirochaetaceae) and the agent of human granulocytic ehrlichiosis (Rickettsiaceae: Ehrlichieae) in Ixodes scapularis (Acari: Ixodidae) collected during 1998 and 1999 from Minnesota. J Med Entomol 39:218-220.
  195. Lebech AM, Hansen K, Branddrup F, et al. 2000. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Molecular Diagn 5:139-150.
  196. LaFleur RL, Callister SM, Dant JC, et al. 2010. One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin. Clin Vaccine Immunol 17:870-874.
  197. Lee SH,Vigliotti VS, Viglotti JS, et al. 2010. Early Lyme disease with spirochetemia-diagnosed by DNA sequencing. BMC Research Notes 3:273.
  198. Leschnik MW, Kirtz G, Khanakah G, et al. 2010. Humoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccine. Clin Vaccine Immunol 17:828-835.
  199. Levine JF. 1995. Ixodes-borne Borrelia spp infections. J Am Vet Med Assoc 207:768-775.
  200. Levy S, O’Connor TP, Hanscom JL, et al. 2002. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet Ther 3:308-315.
  201. Levy SA. 2002. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet Ther 3:420-424.
  202. Levy SA. 2009. Personal observation. Veterinary Clinical and Consulting Services, Kansas City, MO.
  203. Levy SA, Clark KK, Glickman LT. 2005. Infection rates in dogs vaccinated and not vaccinated with an OspA Borrelia burgdorferi vaccine in a Lyme disease-endemic area of Connecticut. Intern J Appl Res Vet Med 3:1-5.
  204. Levy SA, Dombach DM, Barthold SW, et al. 1993. Canine Lyme borreliosis. Compend Contin Educ Pract Vet Small Anim 15:833-846.
  205. Levy SA, Dreesen DW. 1992. Lyme borreliosis in dogs. Canine Pract 17:5-13.
  206. Levy SA, Duray PH. 1988. Complete heart block in a dog seropositive for Borrelia burgdorferi. J Vet Intern Med 2:138-144.
  207. Levy SA, Lissman BA, Ficke CM. 1993b. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. J Am Vet Med Assoc 202:1834-1838.
  208. Levy SA, Magnarelli LA. 1992. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. J Am Vet Med Assoc 200:344-347.
  209. Levy SA, Millership J, Glover S, et al. 2010. Confirmation of presence of Borrelia burgdorferi outer surface protein C antigen and production of antibodies to Borrelia burgdorferi outer surface protein C in dogs vaccinated with a whole-cell Borrelia burgdorferi bacterin. J Appl Res Vet Med 8:123-128.
  210. Levy SA, O’Connor TP, Hanscom JL, et al. 2003. Evaluation of a canine C6 ELISA Lyme disease test for the determination of the infection status of cats naturally exposed to Borrelia burgdorferi. Vet Ther 4:172-177.
  211. Levy SA, O’Connor TP, Hanscom JL, et al. 2008. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs. Clin Vaccine Immunol 15:115-119.
  212. Liang FT, Alvarez AL, Gu Y, et al. 1999. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol 163:5566-5573.
  213. Liang FT, Jacobson RH, Straubinger RK, et al. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol. 38:4160-4166.
  214. Lim S, Irwin PJ, Lee SR, et al. 2010. Comparison of selected canine vector-borne diseases between urban animal shelter and rural hunting dogs in Korea. Parasit Vector 3:32-37.
  215. Lindenmayer J, Weber M, Bryant J, et al. 1990. Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs. J Clin Microbiol 28:92-96.
  216. Lissman BA, Bosler EM, Camay H, et al. 1984. Spirochete associated arthritis (Lyme disease) in a dog. J Am Vet Med Assoc 185:219-220.206. Little SE, Heise SR, Blagburn BL, et al. 2010. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol 26:213-218.
  217. Little SE, Heise SR, Blagburn BL, et al. 2010. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol 26:213-218.
  218. 206a. Little SE, O’Connor TP, Hempstead J, et al. 2010. Ehrlichia ewingii infection and exposure rates in dogs from the south central United States. Vet Parasitol 172:355-360.
  219. Little SE, Varela AS, Luttrell MP, et al. March. 2004. Experimental infection of white-tailed deer and C3H mice with Borrelia lonestari, putative agent of southern tick-associated rash illness (STARI), p 19. In Proceedings of the Annual Spring Symposium 2004, Emerging Infectious Diseases, Threats to the Southeastern U.S., Savannah, GA.
  220. Littman MP. 2003. Canine borreliosis. Vet Clin North Am Small Anim Pract 33:827-862.
  221. Littman MP, Goldstein RE, Labato MA, et al. 2006. ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment and prevention. J Vet Internal Med 20:422-434.
  222. Logigian EL, Kaplan RF, Steere AC. 1999. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 180:377-383.
  223. Lorvrich SD, Callister SM, Lim LC, et al. 1994. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis 170:115-121.
  224. Lovrich SD, La Fleur RL, Jobe DA, et al. 2007. Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease. Clin Vaccine Immunol 14:635-637.
  225. Luke CJ, Huebner RC, Kasmiersky V, et al. 1997. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi. Vaccine 15:739-746.
  226. Ma J, Bulger PA, Dante S, et al. 1995. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochete. J Infect Dis 171:909-915.
  227. Ma J, Hine PM, Clough ER, et al. 1996. Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine. Vaccine 14:1366-1374, 1996.
  228. Magnarelli LA, Anderson JF, Johnson RC, et al. 1994. Comparison of different strains of B. burgdorferi sensu lato used as antigens enzyme-linked immunosorbent assays. J Clin Microbiol 32:1154-1158.
  229. Magnarelli LA, Anderson JF, Kaufmann AF, et al. 1985. Borreliosis in dogs from southern Connecticut. J Am Vet Med Assoc 186:955-959.
  230. Magnarelli LA, Anderson JF, Levine HR, et al. 1990. Tick parasitism and antibodies to Borrelia burgdorferi in cats. J Am Vet Med Assoc 197:63-66.
  231. Magnarelli LA, Anderson JF, Schreier AB, et al. 1987. Clinical and serologic studies of canine borreliosis. J Am Vet Med Assoc 191:1089-1093.
  232. Magnarelli LA, Anderson JF, Schreier AB. 1990. Persistence of antibodies to Borrelia burgdorferi in dogs of New York and Connecticut. J Am Vet Med Assoc 196:1064-1068.
  233. Magnarelli LA, Bushmich SL, Ijdo JW, et al. 2005. Seroprevalence of antibodies against Borrelia burgdorferi and Anaplasma phagocytophilum in cats. Am J Vet Res 66:1895-1899.
  234. Magnarelli LA, Flavell RA, Padula SJ, et al. 1997. Serologic diagnosis of canine and equine borreliosis. Use of recombinant antigens in enzyme-linked immunosorbent assays. J Clin Microbiol 35:169-173.
  235. Magnarelli LA, Levy SA, Ijdo JW, et al. 2001. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J Med Microbiol 50:889-895.
  236. Malawista SE, Barthold SW, Persing DH. 1994. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis 170:1312-1316.
  237. Mandel NS, Senker EG, Bosler EM, et al. 1993. Intrathecal production of Borrelia burgdorferi specific antibodies in a dog with central nervous system Lyme borreliosis. Compend Contin Educ Pract Vet 15:581-585.
  238. Marques AR, Maratin DS, Philipp MT. 2002. Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant Osp A vaccine. J Clin Microbiol 40:2591-2593.
  239. Marshall WF, Telford SR, Rys PN, et al. 1994. Detection of Borrelia burgdorferi DNA in museum specimens of Peromyscus leucopus. J Infect Dis 170:1027-1032.
  240. Master EJ, Ellis B. 1995. Unilateral facial paralysis associated with borreliacidal activity against Borrelia burgdorferi sensu stricto C-1-11. J Spirochetal Tick-Borne Dis 2:42-45.
  241. Masters EJ, Donnell HD. 1995. Lyme and/or Lyme-like disease in Missouri. Medicine 92:346-353.
  242. Masters EJ, Grigery CN, Masters RW. 2008. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infect Dis Clin North Am 22:361-376.
  243. Mather TN, Fish D, Coughlin RT. 1994. Competence of dogs as reservoirs for Lyme disease spirochetes (Borrelia burgdorferi). J Am Vet Med Assoc 205:186-188.
  244. Mathiesen DA, Oliver JH, Kolbert CP, et al. 1997. Genetic heterogeneity of Borrelia burgdorferi in the United States. J Infect Dis 175:98-107.
  245. Matuschka F-R, Endepols S, Richter D, et al. 1996. Risk of urban Lyme disease enhanced by the presence of rats. J Infect Dis 174:1108-1111.
  246. Matuschka F-R, Ohlenbusch A, Eiffert H, et al. 1996. Characteristics of Lyme disease spirochetes in archived European ticks. J Infect Dis 174:424-426.
  247. Maupin GO, Gage KL, Piesman J, et al. 1994. Discovery of an enzootic cycle of Borrelia burgdorferi in Neotoma mexicana and Ixodes spinipalpis from northern Colorado, an area where Lyme disease is nonendemic. J Infect Dis 170:636-643.
  248. May C, Bennett D, Carter SD. 1990. Lyme disease in the dog. Vet Rec 126:293.
  249. May C, Carter SD, Barnes A, et al. 1994. Borrelia burgdorferi infection in cats in the UK. J Small Anim Pract 35:517-520.
  250. 237a. Mazepa AW, Kidd LB, Young KM, 2010. Clinical presentation of 26 Anaplasma phagocytophilum-seorpositive dogs residing in an endemic area. J Am Anim Hosp Assoc 46:405-412.
  251. Menn B, Lorentz S, Naucke TJ. 2010. Imported and travelling dogs as carriers of canine vector-borne pathogens in Germany. Parasites and Vectors 3:34-41.
  252. Minkus G, Breuer W, Wanke R, et al. 1994. Familial nephropathy in Bernese mountain dogs. Vet Pathol 31:421-428.
  253. Moore GE, Guptill LF, Ward MP, et al. 2005. Adverse events diagnosed within 3 days of vaccine administration in dogs. J Am Vet Med Assoc 227:1102-1108.
  254. Moreland KJ, Wilson EA, Simpson RB. 1990. Concurrent Ehrlichia canis and Borrelia burgdorferi infections in a Texas dog. J Am Anim Hosp Assoc 26:635-639.
  255. Moyer PL, Varela AS, Luttrell MP, et al. 2006. White-tailed deer (Odocoileus virginianus) develop spirochetemia following experimental infection with Borrelia lonestari. Vet Microbiol 115:229-236.
  256. Muir P, Fox R, Wu Q, et al. 2010. Seasonal variation in detection of bacterial DNA in arthritic stifle joints of dogs with cranial cruciate ligament rupture using PCR amplification of the 16s RNA. Vet Microbiol 141:127-133.
  257. Muir P, Oldenhoff WE, Hudson AP. 2007. Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog 42:47-55.
  258. Munger RJ. 1990. Uveitis as a manifestation of Lyme borreliosis. J Am Vet Med Assoc 197:811.
  259. Nadelman RB, Horowitz HW, Hsieh TC, et al. 1997. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 337:27-30.
  260. Nadelman RB, Nowaskowski J, Fish D, et al. 2001. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 345:79-84.
  261. Nadelman RB, Sherer C, Mack L, et al. 1990. Survival of Borrelia burgdorferi in human blood stored under blood banking conditions. Transfusion 30:298-301.
  262. Nardelli DT, Callister SM, Schell RF. 2008. Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol 15:21-34.
  263. Nelson DR, Rooney S, Miller NJ, et al. 2000. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer. J Parasitol 86:1232-1238.
  264. Nghiem PP, Schatzberg SJ. 2010. Conventional and molecular diagnostic testing for the acute neurologic patient. J Vet Emerg Crit Care 20:46-61.
  265. Nielssen A, Carr A, Heseltine J. 2002. Update on canine Lyme disease. Vet Med 97:604-609.
  266. Nocton JJ, Bloom BJ, Rutledge BJ, et al. 1996. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 174:623-627.
  267. Nocton JJ, Dressler F, Rutledge BJ, et al. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330:229-234.
  268. Norris DE, Johnson BJB, Piesman J. 1997. Culturing selects for specific genotypes of Borrelia burgdorferi in an enzootic cycle in Colorado. J Clin Microbiol 35:2359-2364.
  269. Nowakowski J, Schwartz I, Nadelman RB, et al. 1997. Culture-confirmed infection and reinfection with Borrelia burgdorferi. Ann Intern Med 127:130-132.
  270. Nyarko E, Grab DJ, Dumler JS. 2006. Anaplasma phagocytophilum-infected neutrophils enhance transmigration of Borrelia burgdorferi across the human blood brain barrier in vitro. Int J Parasitol 36:601-605.
  271. O’Conner TP, Esty KE, Hansom JL, et al. 2004. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6 the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. Clin Diagn Lab Immunol 11:458-462.
  272. Ogden NH, Nuttall PA, Randolph, SE. 1997. Natural Lyme disease cycles maintained via sheep by co-feeding ticks. Parasitology 115:591-599.
  273. 259a. Ogden NH, Trudel L, Artsob H, et al. 2006. Ixodes scapularis ticks collected by passive surveillance in Canada: analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi. J Med Entomol 43:600-609.
  274. Ohlers C. 1991. Tracing the roots of Borrelia burgdorferi. J Am Vet Med Assoc 199:1249-1250.
  275. Ohnishi J, Piesman J, de Silva AM. 2001. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 98:670-675.
  276. Oliver JH. 1996. Lyme borreliosis in the southern United States: a review. J Parasitol 82:926-935.
  277. Oliver JH March. 2004. Borrelia, tick vectors, and reservoir hosts in southern U. S., p 19. In Proceedings of the Annual Spring Symposium 2004, Emerging Infectious Diseases, Threats to the Southeastern U.S., Savannah, GA.
  278. Oliver JH, Cummins GA, Joiner MS. 1993. Immature Ixodes scapularis (Acari: Ixodidae) parasitizing lizards from the southeastern USA. J Parasitol 79:684-689.
  279. Oliver JH, Clark KL, Chandler FW, et al. 2000. Isolation, cultivation, and characterization of Borrelia burgdorferi from rodents and ticks in the Charleston area of South Carolina. J Clin Microbiol 38:120-124.
  280. Oliver JH, Owsley MR, Hutcheson HJ, et al. 1993. Conspecificity of the ticks Ixodes scapularis and I. dammini (Acari: Ixodidae). J Med Entomol 30:54-63.
  281. Otranto D, Dantas-Torres F. 2010. Canine and feline vector-borne diseases in Italy: current situation and perspectives. Parasit Vector 3:2-14.
  282. Overduin LM, van den Bogaard AE. 1997. [Lyme borreliosis in dogs.] Lyme borreliose bij de hond. Tijdschr Diergeneeskd 122:7-9.
  283. Pachner AR, Steiner I. 2007. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol 6:544-52.
  284. Padula SJ, Dias F, Sampieri A, et al. 1994. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol 32:1733-1738.
  285. Pahl A, Kühlbrandt U, Brune K, et al. 1999. Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol 37:1958-1963.
  286. Pal U, de Silva AM, Montgomery RR, et al. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest 106:561-569.
  287. Pal U, Yang X, Chen M, et al. 2004. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 113:220-230.
  288. Pantchev N, Schaper R, Limousin S, et al. 2010. Occurrence of Dirofilaria immitis and tick-borne infections caused by Anaplasma phagocytophila, Borrelia burgdorferi sensu lato and Ehrlichia canis in domestic dogs in France: results of a countrywide serologic survey. Parasitol Res 105:S101-S114.
  289. Patrican LA. 1997. Absence of Lyme disease spirochetes in larval progeny of naturally infected Ixodes scapularis (Acari Ixodidae) fed on dogs. J Med Entomol 34:52-55.
  290. Penrose R, Ramsay EC, New JC, et al. 2000. Borrelia burgdorferi infection in a red wolf (Canis rufus). Infect Dis Rev 2:223-224.
  291. Persing DH, Rutledge BJ, Rys PN, et al. 1994. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis 169:668-672.
  292. Persing DH, Telford SR, Rys PN, et al. 1990. Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks. Science 249:1420-1423.
  293. Philipp MT, Bowers LC, Fawcett PT, et al. 2001. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and humans. J Infect Dis 184:870-878.
  294. Piesman J, Happ CM. 1997. Ability of the Lyme disease spirochete Borrelia burgdorferi to infect rodents and three species of human-biting ticks (blacklegged tick, American dog tick, Lone Star tick) (Acari: Ixodidae). J Med Entomol 34:451-456.
  295. Piesman J, Zeidner NS, Schneider BS. 2003. Dynamic changes in Borrelia burgdorferi populations in Ixodes scapularis (Acari: Ixodidae) during transmission: studies at the mRNA level. Vector-Borne Zoon Dis 3:125-132.
  296. Pound JM, Miller JA, George JE, et al. 2009. The United States Department of Agriculture's Northeast Area-Wide Tick Control Project: summary and conclusions. Vector Borne Zoonot Dis 9:439-448.
  297. Probert WS, Crawford M, Cadiz RB, et al. 1997. Immunization with outer surface protein (Osp) A but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis 175:400-405.
  298. Radolf JD, Caimano MJ. 2008. The long strange trip of Borrelia burgdorferi surface protein C. Mol Microbiol 69:1-4.
  299. Ramamoorthi N, Narasimhan S, Pal U, et al. 2005. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573-577.
  300. Rand PW, Smith RP, Lacombe EH. 1991. Canine seroprevalence and the distribution of Ixodes dammini in an area of emerging Lyme disease. Am J Public Health 81:1331-1334.
  301. Randolph S, Gern L. 2003. Co-feeding transmission and its contribution to the perpetuation of the Lyme disease spirochete Borrelia afzelii. Emerg Infect Dis 9:893-894.
  302. Restrepo BI, Barbour AG. 1994. Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell 78:867-876.
  303. Rice Conlon JA, Mather TN, Tanner P, et al. 2000. Efficacy of a nonadjuvanted, outer surface protein A recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet Ther 1:96-107.
  304. Richter D, Allgower R, Matuschka F-R. 2002. Co-feeding transmission and its contribution to the perpetuation of the Lyme disease spirochete Borrelia afzelii. Emerg Infect Dis 8:1421-1425.
  305. Richter D, Allgower R, Matuschka F-R. 2003. Co-feeding transmission and its contribution to the perpetuation of the Lyme disease spirochete Borrelia afzelii. Emerg Infect Dis 9:895-896.
  306. Richter D, Schlee DB, Matuschka F-R. 2003. Relapsing fever-like spirochetes infecting European vector tick of Lyme disease agent. Emerg Infect Dis 9:697-701.
  307. Roberts ED, Bohm RP, Lowrie RC, et al. 1998. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 178:722-732.
  308. Roush JK, Manley PA, Dueland RT. 1989. Rheumatoid arthritis subsequent to Borrelia burgdorferi infection in two dogs. J Am Vet Med Assoc 195:951-953.
  309. Saint Girons I, Gern L, Gray JS, et al. 1998. Identification of Borrelia burgdorferi sensu lato species in Europe. Zentrablatt Bakteriol 287:190-195.
  310. Salinas-Metendez JA, Tamez-Gonzalez R, Welsh-Lozano O, et al. 1995. Detection of Borrelia burgdorferi DNA in human skin biopsies and dog synovial fluid by the polymerase chain reaction. Rev Latinoam Microbiol 37:7-10.
  311. Sanders NA, Dambach DM, Littman MP. 1997. Clinical characterization of a rapidly progressive and fatal glomerulonephritis associated with Borrelia burgdorferi infection in the dog ("Lyme nephritis") (abstract). J Vet Intern Med 11:127.
  312. Sarih M, Jouda F, Gern L, et al. 2003. First isolation of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks in Morocco. Vector-Borne Zoonot Dis 3:133-139.
  313. Scheckelhoff MR, Telford SR, Hu LT. 2006. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine 24:1949-1957.
  314. Schillhorn Van Veen TW, Murphy AJ, Colmery B. 1993. False positive Borrelia burgdorferi antibody titers associated with periodontal disease in dogs. Vet Rec 132:512.
  315. Schneider BS, Schriefer ME, Dietrich G, et al. 2008. Borrelia bissettii isolates induce pathology in a murine disease model. Vector Borne Zoonotic Dis 8:623-633.
  316. Schutzer SE, Coyle PK, Krupp LB, et al. 1997. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J Clin Invest 100:763-767.
  317. Schutzer SE, Coyle PK, Reid P, et al. 1999. Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 282:1942-1946.
  318. Schwan TG, Hinnebosch BJ. 1998. Bloodstream-versus tick-associated variants of a relapsing fever bacterium. Science 280:1938-1940.
  319. Schwan TG, Piesman J. 2000. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38:382-388.
  320. Schwan TG, Piesman J. 2002. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 8:115-121.
  321. Schwan TG, Piesman J, Golde WT, et al. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 92:2909-2913.
  322. Schwan TG, Policastro PF, Miller Z, et al. 2003. Tick-borne relapsing fever caused by Borrelia hermsii, Montana. Emerg Infect Dis 9:1151-1154.
  323. Schwan TG, Raffel SJ, Schrumpf ME, et al. 2005. Phylogenetic analysis of the spirochetes Borrelia parkeri and Borrelia turicatae and the potential for tick-borne relapsing fever in Florida. J Clin Microbiol 43:3851-3859.
  324. Schwan TG, Schrumph ME, Hinnebusch BJ, et al. 1996. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol 34:2483-2492.
  325. Scoles GA, Papero M, Beati L, et al. 2001. A relapsing fever spirochete transmitted by Ixodes scapularis ticks. Vector Borne Disease 1:21-34.
  326. Scott JD, Fernando K, Banerjee SN, et al. 2001. Birds disperse ixodid (Acari: Ixodidae) and Borrelia burgdorferi-infected ticks in Canada. J Med Entomol 38:493-500.
  327. Shanies T, Goldstein R, Njaa B, et al. 2005. The search for intact Borrelia burgdorferi bacteria in kidneys from dogs suspected of suffering from "Lyme nephritis" [abstract]. Proc Annu Meet Am Coll Vet Intern Med 19:471.
  328. Shapiro ED, Gerber MA. 2000. Lyme disease. Clin Infect Dis 31:533-542.
  329. Shapiro ED, Gerber MA, Holabird NB, et al. 1992. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer tick bites. N Engl J Med 27:1769-1773.
  330. Shaw SE, Binns SH, Birtles RJ, et al. 2005. Molecular evidence of tick-transmitted infections in dogs and cats in the United Kingdom. Vet Rec 157:645-648
  331. Sheets JT, Rossi C, Kearney BJ, et al. 2000. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of Borrelia burgdorferi exposure in dogs. J Am Vet Med Assoc 216:1418-1422.
  332. Shin SJ, Chang YF, Jacobson RH, et al. 1993. Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs. Vet Microbiol 36:161-174.
  333. Sigal LH. 1994. The polymerase chain reaction assay for Borrelia burgdorferi in the diagnosis of Lyme disease. Ann Intern Med 120:520-521.
  334. Sigal LH, Williams S. 1997. A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease. Infect Immun 65:1722-1728.
  335. Sigal LH, Zahradink JM, Lavin P, et al. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein to prevent Lyme disease. N Eng J Med 339:216-222.
  336. Skotarczak B. 2002. Canine borreliosis—epidemiology and diagnostics. Ann Agric Environ Med 9:137-140.
  337. Skotarczak B, Wodecka B, Rymaszewska A, et al. 2005. Prevalence of DNA and antibodies to Borrelia burgdorferi sensu lato in dogs suspected of borreliosis. Ann Agric Environ Med 12: 199-205.
  338. Smith RP, Rand PW, Lacombe EH, et al. 1996. Role of bird migration in the long-distance dispersal of Ixodes dammini, the vector of Lyme disease. J Infect Dis 174:221-224.
  339. Smith RP Jr, Rand PW, Lacombe EH, et al. 1993. Norway rats as reservoir hosts for Lyme disease spirochetes on Monhegan Island, Maine. J Infect Dis 168:687-691.
  340. Sood SK, Salzman MB, Johnson BJB, et al. 1997. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis 175:996-999.
  341. Speck S, Failing K, Reiner B, et al. 2002. Evaluation of different media and a BGM cell culture assay for isolation of Borrelia burgdorferi sensu lato from ticks and dogs. Vet Microbiol 89:291-302.
  342. Speck S, Reiner B, Streich WJ, et al. 2007. Canine borreliosis: a laboratory diagnostic trial. Vet Microbiol 120:132-141.
  343. Speck S, Reiner B, Wittenbrink MM. 2001. Isolation of Borrelia afzelii from a dog. Vet Rec 149:19-20.
  344. Spencer JA, Butler JM, Stafford KC, et al. 2003. Evaluation of permethrin and imidacloprid for prevention of Borrelia burgdorferi transmission from blacklegged ticks (Ixodes scapularis) to Borrelia burgdorferi-free dogs. Parasitol Res 90(Suppl 3):S106-S107.
  345. 330a. Spolidorio MG, Labruna MB, Machado RZ, et al. 2010. Survey for tick-borne zoonoses in the state of Espirito Santo, southeastern Brazil. Am J Trop Med Hyg 83:201-206.
  346. Steere AC, Berandi VP, Weeks KE, et al. 1990. Evaluation of intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 161:1203-1209.
  347. Steere AC, Sikand VK, Meurice F, et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface lipoprotein A with adjuvant. N Eng J Med 339:209-215.
  348. Steere AC, Sikand VK, Schoen RT, et al. 2003. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 37:528-532.
  349. Steere AC, Taylor E, McHugh GL, et al. 1993. The overdiagnosis of Lyme disease. JAMA 269:1812-1816.
  350. Stevenson B, Schwan TG, Rosa PA. 1995. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63:4535-4539.
  351. Stone EG, Lacombe EH, Rand PW. 2005. Antibody testing and Lyme disease risk. Emerg Infect Dis 11:722-724.
  352. Straubinger RK. 1997. Unpublished observations. Cornell University, Ithaca, NY.
  353. Straubinger RK. 2000. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J Clin Microbiol 38:2191-2199.
  354. Straubinger RK, Rao TD, Davidson E, et al. 2002. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine. Vaccine 20:181-193.
  355. Straubinger RK, Straubinger AF, Härter L, et al. 1997. Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect Immun 65:1273-1285.
  356. Straubinger RK, Straubinger AF, Summers BA, et al. 1998. Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 110:874-881.
  357. Straubinger RK, Straubinger AF, Summers BA, et al. 2000. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J Infect Dis 181:1069-1081.
  358. Straubinger RK, Sumers BA, Yung-Fu C, et al. 1997. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 35:111-116.
  359. Straubinger RK, Yung-Fu C, Jacobson RH, et al. 1995. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J Clin Microbiol 33:2745-2751.
  360. Strother KO, Broadwater A, de Silva A. 2005. Plasmid requirements for infection of ticks by Borrelia burgdorferi. Vector Borne Zoonotic Dis 5:237-245.
  361. Sugiyama Y, Sugiyama F, Yagami K. 1993. Comparative study on cross reaction of leptospiral antibodies in several serological tests to detect antibodies to Borrelia burgdorferi in dogs. J Vet Med Sci 55:149-151.
  362. Summers BA, Straubinger AF, Jacobson RH, et al. 2005. Histopathological studies of experimental lyme disease in the dog. J Comp Pathol 133:1-13.
  363. Telford SR III, Mather TN, Moore SI, et al. 1988. Incompetence of deer as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 39:105-109.
  364. Tilly K, Krum JG, Bestor A, et al. 2006. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 74:3554-3564.
  365. Tilly K, Rosa PA, Stewart PE. 2008. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am 22:217-234.
  366. Töpfer KH, Straubinger RK. 2007. Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent. A study with five commercial vaccines using two different vaccination schedules. Vaccine 25:314-326.
  367. Torrence ME, Jenkins SR, Levine JF, et al. 1990. Serosurvey of shelter dogs in Virginia for antibodies to Borrelia burgdorferi. Prev Vet Med 10:41-46.
  368. Trevejo RT, Krause PJ, Sikand VK, et al. 1999. Evaluation of two-test serodiagnostic method for early Lyme disease. J Infect Dis 179:931-938.
  369. 353a. Tzipory N, Crawford PC, Levy JK. 2010. Prevalence of Dirofilaria immitis, Ehrlichia canis, and Borrelia burgdorferi in pet dogs, racing greyhounds, and shelter dogs in Florida. Vet Parasitol 171:136-139.
  370. Varela AS, Luttrell MP, Howerth EW, et al. 2004. First culture isolation of Borrelia lonestari, putative agent of Southern tick-associated rash illness. J Clin Microbiol 42:1163-1169.
  371. Varela AS, Luttrell MP, Howerth EW, et al. March. 2004. First culture isolation of Borrelia lonestari, putative etiologic agent of southern tick-associated rash illness (STARI), p 19. In Proceedings of the Annual Spring Symposium 2004, Emerging Infectious Diseases Threats to the Southeastern U.S., Savannah GA.
  372. 355a. Wagner B, Freer H, Rollins H, et al. 2011. A florescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum. Vet Immunol Immunopathol 140:190-198.
  373. Wallich R, Brenner C, Kramer MD, et al. 1995. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG of Borrelia burgdorferi expressed only in vivo. Infect Immun 63:3327-3335.
  374. Wallich R, Jahraus O, Simon MM. 2002. Prophylactic vaccination against Lyme borreliosis for man and dogs and new strategies to treat established B. burgdorferi infections. Int J Med Microbiol 291(Suppl 33):147-149.
  375. Wang G. 2002. Direct detection methods for Lyme Borrelia, including the use of quantitative assays. Vector Borne Zoonotic Dis 2:223-231.
  376. Wang G, Ojaimi C, Wu H, et al. 2002. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 186:782-791.
  377. Wang G, van Dam AP, Schwartz I, et al. 1999. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12:633-653.
  378. Wasomen TL, Sebring RW, Blumer BM, et al. 1992. Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis. J Am Vet Med Assoc 201:412-418.
  379. Welc-Faleciak R, Rodo A, Sinski E, et al. 2010. Babesia canis and other tick-borne infections in dogs in Central Poland. Vet Parasit 166:191-198.
  380. Wesson DM, McLain DK, Oliver JH, et al. 1993. Investigation of the validity of species status of Ixodes dammini (Acari: Ixodidae) using rDNA. Proc Natl Acad Sci USA 90:10221-10225.
  381. Whitney MS, Schwan TG, Sultemeier KB, et al. 2007. Spirochetemia caused by Borrelia turicatae infection in 3 dogs in Texas. Vet Clin Pathol 36:212-216.
  382. Wikle RE, Fretwell B, Jarecki M, et al. 2006. Canine Lyme disease: one year duration of immunity elicited with a canine 0spA monovalent Lyme vaccine. Intern J Appl Res Vet Med 4:23-28.
  383. Wilske B, Schierz G, Preac-Mursic V, et al. 1986. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 153:304-314.
  384. Wodecka B, Rymaszewska A, Sawczuk M, et al. 2009. Detectability of tick-borne agents DNA in the blood of dogs undergoing treatment for borreliosis. Ann Agric Environ Med 16:9-14.
  385. Wormser BP, Liveris D, Nowakowski J, et al. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 180:720-725.
  386. Wormser GP, Bittker S, Cooper D, et al. 2001. Yield of large-volume blood culture in patients with early Lyme disease. J Infect Dis 184:1070-1072.
  387. 369a. Wormser GP, Dattwyler RJ, Shapiro ED, et al. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 43:1089-1134.
  388. Wormser GP, Liveris D, Hanincová K, et al. 2008. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin Infect Dis 47:910-914.
  389. Wormser GP, Nadelman RB, Dattwyler RJ, et al. 2000. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31:S1-S14.
  390. Wright JC, Chambers M, Mullen GR, et al. 1997. Seroprevalence of Borrelia burgdorferi in dogs in Alabama, USA. Prev Vet Med 31:127-131.
  391. Wright SA, Thompson MA, Miller MJ, et al. 2000. Ecology of Borrelia burgdorferi in ticks (Acari: Ixodidae), rodents, and birds in the Sierra Nevada foothills, Placer County, California. J Med Entomol 37:909-918.
  392. Xu Q, McShan K, Liang FT. 2008. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol Microbiol 69:15-29.
  393. 374a. Yrjanainen H, Hytonen J, Hartiala P, et al. 2010. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infectged mice after ceftriaxone treatment. APMIS 118:665-673.
  394. Yu LP, Smith GN, Brandt KD, et al. 1992. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 35:1150-1159.
  395. Zhang YQ, Mathiesen D, Kolbert CP, et al. 1997. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection. J Clin Microbiol 35:233-238.
  396. Zhong WM, Gern L, Sehle T, et al. 1999. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol 29:946-949.
  397. Zeidner NS, Núncio MS, Schneider BS, et al. 2001. A Portuguese isolate of Borrelia lusitaniae induces disease in C3H/HeN mice. J Med Microbiol 50:1055-1060.